Fibrinolysis is the breakdown of fibrin within blood clots. The two types of fibrinolysis are primary and secondary fibrinolysis.

Secondary fibrinolysis occurs as a result of an external stimulus, such as medication or a medical condition, whereas primary fibrinolysis occurs naturally. Fibrinolysis is strictly regulated by several cofactors, inhibitors, and receptors. Plasmin is the major protein responsible for fibrinolysis. Urokinase and tissue plasminogen activator (tPA) convert plasminogen to plasmin (up A). tPA is produced by endothelial cells, whereas uPA is produced by monocytes, macrophages, and urinary epithelial cells. uPA has a lower affinity for plasminogen than tPA and does not require fibrin to initiate plasmin production.

Plasmin activates tPA and uPA, causing a positive feedback loop in which the plasminogen activation leads to more plasminogen activation. This positive feedback loop is crucial because it is critical to remove blood clots that have served their role.

1. Primary Fibrinolysis: A Natural Physiological Mechanism

2. Secondary fibrinolysis is the breakup of clots caused by medication, disease, or other factors. Fibrinolysis refers to the process of dissolving a generated thrombus by endogenous plasmin. Plasmin can disrupt certain linkages in fibrin polymers generated by factor XIIIa’s cross-binding action. 

The fibrinolytic system is primarily responsible for the following functions:

• Fibrinolytic activation gets started in conjunction with the plasmatic coagulation system to restrict the production of thrombi.

• Healing or recanalisation of a thrombotic blockage in a vessel.

Progression of Fibrinolytic Activity

The tissue-type plasminogen activator is primarily responsible for the beginning of fibrinolysis (t-PA). t-PA binds fibrin with its substrate plasminogen, resulting in fibrin-dependent proteolysis. In general, the starting stage of fibrinolysis is as complex as that of coagulation and is predicated on the conversion of the zymogen plasminogen into its active serine protease form of plasmin. 

This process’s regulation must be particularly efficient for two reasons:

• Healthy tissue forms would likewise be dissolved by systemic proteolysis.
• Premature fibrinolysis could jeopardise the critical acute clot stability.

Primary Fibrinolysis Mechanism

Primary fibrinolysis usually occurs after clot retraction, when the specific clot has evidently and already contracted significantly in size. Plasmin is known as a proteolytic enzyme that degrades the fibrin mesh and is the major enzyme in initial fibrinolysis. Plasmin cleaves fibrin at several sites, resulting in circulating pieces that are removed with the help of any other proteases or the liver and the kidney. In the liver, plasminogen, an inactive version of plasmin, is created. Plasminogen is a protein that is not able to leave the fibrin and keeps on circulating inside the bloodstream. Despite that, it gets absorbed inside the particular clot and then starts inside the plasmin afterwards. Tissue plasminogen activator (t-PA) and urokinase, an enzyme present in the urine, convert plasminogen to plasmin.

The Fibrinolysis Process

• tPA, plasminogen activator inhibitor 1 and 2, urokinase, and factor XIa, XIIa Kallakrein first act on the plasmogen.
• Plasma is then affected by o2 antiplasmin and o2 macroglobulin.
• Thrombin and thrombin-activatable fibrinolysis inhibitors act on fibrin and fibrin breakdown products.
• For fibrinolysis, blue arrows indicate stimulation, whereas red arrows indicate inhibition.
• T-PA is progressively released inside the bloodstream by the blood vessel’s injured endothelium.
• Plasminogen activator inhibitor-1 and plasminogen activator inhibitor-2 both suppress T-PA and urokinase (PAI-1 and PAI-2).
• Plasmin, on the other hand, increases plasmin production by developing better and more active versions of both tissue plasminogen activator (tPA) and urokinase.
• After the degradation of fibrin of plasmin, macrophages phagocytise and eliminate old active platelets from the platelet plug.
• Plasmin is inactivated by alpha 2-antiplasmin and alpha 2-macroglobulin.
• The same activity of plasmin is also inhibited by thrombin-activatable fibrinolysis inhibitor (TAFI), which alters fibrin to make it more resistant to the plasminogen induced by tPA.
• Plasmin is lowered when the fibrin clot is destroyed, resulting in reverse and a negative type of feedback mechanism.  

Conclusion

Fibrin is important in hemostasis because it is both the prime component of the clotting cascade and the final substrate for fibrinolysis. Clot shape, fibrinogen isoforms and polymorphisms, the rate of thrombin synthesis, the reactivity of thrombus-associated organisms such as platelets, and the general biochemical milieu all have a significant impact on fibrinolysis effectiveness.